Watch and Wait Approach for Prostate Cancer A Johns Hopkins study of 769 men from across the United States recently diagnosed with low - grade prostate
cancer supports delaying treatment as long as the cancer's progression and tumor growth are closely monitored through «active surveillance» and there is no dramatic worsening of the disease over time.
«Results from our study
support the argument that declining PSA screening may result in
delayed diagnosis, potentially leading to avoidable
cancer deaths,» according to John M. Corman, MD, Virginia Mason, Seattle, WA.